Brief: Tianjin Development Says Qtrly Total Operating Income Rmb364.8 Million For Tianjin Lisheng Pharmaceutical
25/04/2024 02:03
April 25 (Reuters) - Tianjin Lisheng Pharmaceutical Co
Ltd 002393.SZ :
* QTRLY TOTAL OPERATING INCOME RMB364.8 MILLION VERSUS
RMB335.6
MILLION FOR TIANJIN LISHENG PHARMACEUTICAL
* QTRLY NET PROFIT ATTRIBUTABLE FOR TIANJIN LISHENG
PHARMACEUTICAL
RMB59.2 MILLION VERSUS RMB46.5 MILLION
Further company coverage: 002393.SZ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tianjin Development Holdings
See all newsHong Kong's Tianjin Development HY revenue on lower pharmaceutical, utilities sales
Brief: Tianjin Development Says Teng Fei Resigns As Chairman And Executive Director
Brief: Tianjin Development Says H1 2026 Net Profit Seen At RMB 73-83 Million For Tianjin Lisheng Pharmaceutical
Brief: Tianjin Development Says Lisheng Pharmaceutical Subscribes To Investment Products Totaling RMB180 Million
Brief: Tianjin Development Says Tianjin Lisheng Pharmaceutical QTRLY Operating Income RMB 332.28 Mln